Intermedin (Adrenomedullin-2)

Best for

Consider alternatives if

Covers reconstitution · step-by-step technique · storage · a sample daily schedule.

Common side effects · experienced by some users

• Mild discomfort at treatment site

  Some users experience mild discomfort, which is among the most commonly reported effects with Intermedin (Adrenomedullin-2). This typically resolves within a few days as the body adjusts.

  Management: Apply ice if needed. Rotate treatment sites. These symptoms typically improve within the first week of use.

• Flushing and mild facial redness

  Occurs in 15-25% of users, typically within 30-60 minutes of injection. Relates to Intermedin's vasodilatory effects causing blood vessel dilation in facial skin. Flushing episodes usually last 15-30 minutes and are usually accompanied by a sensation of warmth. Intensity diminishes with repeated doses as the body adapts.

  Management: Keep treatment environment cool. Have cool water available to drink. Avoid hot environments and strenuous activity immediately after injection. Flushing is harmless and does not indicate an adverse reaction. No treatment is typically needed unless flushing causes significant discomfort.

• Dizziness or lightheadedness

  Affects 10-15% of users and is directly related to Intermedin's blood pressure-lowering effects through vasodilation. Typically mild and transient, lasting 15-45 minutes. More likely to occur when standing or changing positions. Usually resolves within the first week as cardiovascular adaptation occurs.

  Management: Rise slowly from lying or sitting positions. Stay seated for 5-10 minutes after injection if possible. Remain well hydrated. Avoid driving or operating machinery for 1-2 hours post-injection. Report persistent or severe dizziness to your healthcare provider, as it may indicate need for dose adjustment.

• Mild headache

  Occurs in 8-12% of patients, usually mild tension-type headaches. Often correlates with blood pressure changes and vasodilation. Most headaches occur within the first 1-2 hours post-injection and resolve within 1-4 hours. Frequency typically decreases after first few doses.

  Management: Apply cool or warm compress to forehead. Stay hydrated with plenty of water. Rest in a quiet environment if needed. Acetaminophen is safe to use. Avoid NSAIDs as they may interfere with Intermedin's anti-inflammatory benefits. Most headaches resolve without intervention.

• Injection site reactions (redness, itching, swelling)

  Localized reactions occur in 10-20% of users, typically mild and self-limiting. Redness and mild swelling usually appear within 30 minutes and resolve within 2-4 hours. Itching at the site is less common (3-5%) but also transient. Reactions are rarely severe enough to require treatment discontinuation.

  Management: Rotate injection sites to prevent repeated trauma to the same area. Apply ice immediately after injection for 5-10 minutes to reduce local inflammation. Avoid scratching the site. Most reactions resolve without intervention. Severe or worsening reactions warrant medical evaluation.

• Nausea or mild gastrointestinal discomfort

  Affects 5-10% of users, usually mild and transient. Often related to blood pressure changes or occurs on an empty stomach. Nausea typically peaks 30-60 minutes post-injection and resolves within 1-2 hours. GI discomfort is rarely severe and does not typically persist with continued use.

  Management: Take injections with a light meal or snack. Avoid greasy or heavy foods immediately before or after injection. Ginger tea may help with mild nausea. Stay hydrated. If nausea is bothersome, taking the injection in the evening allows sleep through the symptoms. Symptoms typically resolve within the first week.

• Fatigue or mild energy changes

  Occurs in 8-15% of users, usually mild and brief. Fatigue may relate to the cardiovascular adjustment and vasodilation effects. Some users report temporary energy dip 1-2 hours post-injection, while others experience improved energy with the stress-reducing and circulatory benefits. Effects typically normalize within days.

  Management: Plan important activities for times other than 1-2 hours post-injection. Allow rest time if needed. Ensure adequate sleep (7-8 hours nightly). Maintain regular exercise as tolerated; gentle movement may improve energy. Many users report improved overall energy after 1-2 weeks as cardiovascular benefits accumulate.

• Transient hypotension (temporary low blood pressure)

  Blood pressure may drop 10-20 mmHg within 30-90 minutes of injection in 15-20% of users due to Intermedin's vasodilatory effects. This is usually mild, asymptomatic, and self-correcting within 2-4 hours. More pronounced in those already taking blood pressure medications.

  Management: Monitor blood pressure if you have hypertension history. Sit or lie down after injection if possible. Avoid strenuous activity for 1-2 hours post-injection. Stay well hydrated. Rise slowly from lying positions. If symptomatic hypotension occurs (severe dizziness, fainting), notify your healthcare provider immediately; dose reduction may be needed.

• Mild palpitations (in some individuals)

  Occurs in 5-8% of users and represents the heart's natural response to improved blood flow and vasodilation. Palpitations are typically benign sensations of the heartbeat (awareness rather than irregular rhythm). Usually occur within 30-60 minutes post-injection and resolve within 1-2 hours. No underlying arrhythmia is typically present.

  Management: Palpitations are usually harmless and reflect the cardiovascular benefits of the medication. Practice deep breathing exercises if anxious. Avoid caffeine and stimulants around injection time. Lie down and rest if palpitations cause anxiety. Report palpitations accompanied by chest pain, shortness of breath, or fainting to your healthcare provider immediately.